DRTS · Alpha Tau Medical Ltd.
Market Cap
$1.39B
Shares
92.48M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$15.24
Open$15.60
Day$15.10–15.63
52W close$3.47–15.49
Avg vol 30d614K
Short int3.1M · 3.3% float · 4.3d
Short vol68%
Last earningsMay 11, 2026
DataMar 2021–Sep 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+15.2%
Year over year · more shares
Price change (1Y)
+300.0%
Trailing year
Short interest
3.3%
Latest settlement · 4.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 14.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+64%
above
Price vs 50-day avg
+11%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
98%
near high
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+6%
trailing
6-month return
+122%
trailing
YTD return
+208%
this year
Relative strength
+102%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $14 › 200d $9 — 50d above 200d
Institutional flow
Accumulating
+27% holders QoQ · +28 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.34% of float · ▲ +1.1% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
89 holders — near 3-yr high, broad support
Squeeze score
65
elevated · 0–100
Fundamentals
EPS growth
−18%
Y/Y
Free cash flow
$-32.8M
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−24%
past year
ATR
4.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+64%
Bullish
Price vs 50-day avg
+11%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
98%
Bullish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $14 › 200d $9 — 50d above 200d
Institutional flow
Accumulating
+27% holders QoQ · +28 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.34% of float · ▲ +1.1% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
89 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3
Now $15 · 98%
Range high $15
vs 200-day avg +64%
vs 50-day avg +11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DRTS
this stock
Alpha Tau Medical Ltd.
|
$1.39B | +207.9% | — | — | 3.3% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.84B | +12.1% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$80.80B | +1.7% | +20.8% | 19.4 | 2.5% |
|
MRNA
Moderna, Inc.
|
$61.50B | +422.3% | +4.3% | — | 9.8% |
|
ARGX
Argenx SE
|
$60.93B | +17.8% | — | — | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DRTS | +5.6% | +6.1% | +122.2% | +8.0% | +207.9% |
| SPY | -0.3% | -0.1% | +20.1% | -0.7% | +11.7% |
| vs SPY | +6.0% | +6.3% | +102.0% | +8.7% | +196.2% |